EOLS FY 2019 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena

EOLSEvolus, Inc.

$338M

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$35M

Gross Profit

$27M77.1% margin

Operating Income

-$99M-283.3% margin

Net Income

-$90M-257.8% margin

EPS (Diluted)

$-3.19

Cash Flow

Operating Cash Flow

-$93M

Free Cash Flow

-$98M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$240M

Total Liabilities

$161M

Stockholders' Equity

$79M

Cash & Equivalents

$110M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$0	—
Gross Profit	$27M	-$9,000	+299111.1%
Operating Income	-$99M	-$46M	-114.4%
Net Income	-$90M	-$47M	-92.1%